LBA-5 ANCHOR CRC: a single-arm, phase 2 study of encorafenib, binimetinib plus cetuximab in previously untreated BRAF V600E-mutant metastatic colorectal cancer von Grothey, A., Tabernero, J., Taieb, J., Yaeger, R., Yoshino, T., Maiello, E., Fernandez, E. Elez, Casado, A. Ruiz, Ross, P., André, T., Kato, T., Ruffinelli, J., Graham, J., den Eynde, M. Van, Vera, R., Jean, B., Roussel, E. Carriere, Cahuzac, C., Issiakhem, Z., Vedovato, J., Cutsem, E. Van

Volltext